Zydus Pharmaceuticals (USA) Inc recalls Entecavir Tablets
- Published
- 8 Oct 2025
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.
Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.
- Brand / company
- Zydus Pharmaceuticals (USA) Inc
- Codes / lots
- Lot#: E409308, Exp 12/31/2026 | Lot#: E409309, Exp 12/31/2026
- Distribution
- Distributed Nationwide in the USA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 8 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.